NCT06683274 Bascom Cleft Lift for Primary Wound Healing in Complex and Recurrent Sacrococcygeal Pilonidal Sinus Disease
| NCT ID | NCT06683274 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Albert Schweitzer Ziekenhuis, Netherlands |
| Condition | Pilonidal Sinus |
| Study Type | OBSERVATIONAL |
| Enrollment | 58 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 58 participants in total. It began in 2025-02-20 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to improve care for patients with complex or recurrent pilonidal sinus disease by developing and implementing a best practice care pathway, including a standardized cleft lift operation. The main question it aims to answer is: Does a best practice care pathway with standardized cleft lift operation lead to shorter wound healing time and time to return to normal activities, compared to current standard care, with traditional excision techniques.
Eligibility Criteria
Inclusion Criteria: * 16 years of age and older * Symptomatic complex or recurrent pilonidal sinus disease * Planned for surgical treatment * Signed informed consent Exclusion Criteria: * Pregnant * Insufficient understanding of the Dutch language or otherwise unable to give consent
Contact & Investigator
Robert Smeenk, MD, PhD
PRINCIPAL INVESTIGATOR
Albert Schweitzer Ziekenhuis, Netherlands
Frequently Asked Questions
Who can join the NCT06683274 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Pilonidal Sinus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06683274 currently recruiting?
Yes, NCT06683274 is actively recruiting participants. Contact the research team at m.r.goudberg@asz.nl for enrollment information.
Where is the NCT06683274 trial being conducted?
This trial is being conducted at Dordrecht, Netherlands.
Who is sponsoring the NCT06683274 clinical trial?
NCT06683274 is sponsored by Albert Schweitzer Ziekenhuis, Netherlands. The principal investigator is Robert Smeenk, MD, PhD at Albert Schweitzer Ziekenhuis, Netherlands. The trial plans to enroll 58 participants.